Mixed
Biomarker-based personalized nutrition plans do not result in greater weight loss or improvements in cardiometabolic health compared to a generic, generally healthy diet in individuals with overweight or obesity.
If you have overweight or obesity, following a generally healthy, balanced diet that provides enough food to satisfy you will result in similar weight loss and health improvements as following a highly personalized, biomarker-driven diet plan. You do not need to undergo expensive metabolic testing or follow complex personalized rules to achieve significant health benefits; consistency with a healthy, isocaloric diet is sufficient.
Personalized dietary plans did not result in greater benefits over a generic, but generally healthy diet, in this 10-week clinical trial.
Why this rating
Double-blinded, randomized, parallel intervention with 100 participants, though short duration (10 weeks).
Source
A double-blinded, randomized, parallel intervention to evaluate biomarker-based nutrition plans for weight loss: The PREVENTOMICS study
Mona Adnan Aldubayan et al. · Clinical Nutrition · 2022
DOI 10.1016/j.clnu.2022.06.032
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →